Comparison of inductively coupled plasma atomic emission spectrometry and inductively coupled plasma mass spectrometry with quantitative neutron capture radiography for the determination of boron in biological samples from cancer therapy

被引:48
作者
Probst, TU
Berryman, NG
Lemmen, P
Weissfloch, L
Auberger, T
Gabel, D
Carlsson, J
Larsson, B
机构
[1] TECH UNIV MUNICH, INST ORGAN CHEM & BIOCHEM, D-85747 GARCHING, GERMANY
[2] TECH UNIV MUNICH, KLINIKUM RECHTS ISAR, CLIN & POLYCLIN RADIOTHERAPY & RADIOL ONCOL, D-81675 MUNICH, GERMANY
[3] UNIV INNSBRUCK, CLIN RADIOTHERAPY, A-6020 INNSBRUCK, AUSTRIA
[4] UNIV BREMEN, DEPT CHEM, D-28334 BREMEN, GERMANY
[5] UNIV UPPSALA, DEPT RADIAT SCI, DIV PHYS BIOL, S-75121 UPPSALA, SWEDEN
[6] PAUL SCHERRER INST, CH-5232 VILLIGEN, SWITZERLAND
关键词
inductively coupled plasma mass spectrometry; inductively coupled plasma atomic emission spectrometry; quantitative neutron capture radiography; boron neutron capture therapy; cancer therapy; microwave digestion rac-1-(9-o-carboranyl)nonyl-2-methylglycero-3-phosphocholine;
D O I
10.1039/a700445a
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A boron-containing compound was administered to tumor-bearing mice and the time-dependent concentration was determined by ICP-AES, ICP-MS and quantitative neutron capture radiography (QNCR). The atomic spectrometric procedures were optimized to minimize analyte losses during microwave digestion. Non-spectroscopic interferences were investigated in detail and appropriate internal standards were established for ICP-MS. The best detection limits achieved for boron were 30 ng ml(-1) by ICP-AES and 0.3 ng ml(-1) by ICP-MS. The respective determination limits in the digested and diluted tissue samples were 0.4 mu g ml(-1) and 3 ng ml(-1). The results of the spectrometric determinations were confirmed by QNCR of whole-body cryosections of six mice, A brief description of the metabolism of the boron compound is given.
引用
收藏
页码:1115 / 1122
页数:8
相关论文
共 70 条
[1]  
[Anonymous], BORON NEUTRON CAPTUR
[2]   DISTRIBUTION AND METABOLISM OF SYNTHETIC ALKYL ANALOGS OF LYSOPHOSPHATIDYLCHOLINE IN MICE [J].
ARNOLD, B ;
REUTHER, R ;
WELTZIEN, HU .
BIOCHIMICA ET BIOPHYSICA ACTA, 1978, 530 (01) :47-55
[3]  
AYSOLA P, 1987, ANAL CHEM, V59, P1583
[4]  
Barnes RM, 1996, FRESEN J ANAL CHEM, V355, P433
[5]  
BAUER WF, 1989, STRAHLENTHER ONKOL, V165, P176
[6]   USE OF EXTERNAL CALIBRATION FOR THE DETERMINATION OF TRACE-METALS IN BIOLOGICAL-MATERIALS BY INDUCTIVELY COUPLED PLASMA MASS-SPECTROMETRY [J].
BEAUCHEMIN, D ;
MCLAREN, JW ;
BERMAN, SS .
JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY, 1988, 3 (06) :775-780
[7]   IN-VIVO DETECTION OF A BORON-NEUTRON-CAPTURE AGENT IN MELANOMA BY PROTON OBSERVED H-1 B-10 DOUBLE-RESONANCE [J].
BENDEL, P ;
ZILBERSTEIN, J ;
SALOMON, Y .
MAGNETIC RESONANCE IN MEDICINE, 1994, 32 (02) :170-174
[8]   CLINICAL PHASE-I PILOT-STUDY OF THE ALKYL LYSOPHOSPHOLIPID DERIVATIVE ET-18-OCH3 [J].
BERDEL, WE ;
FINK, U ;
RASTETTER, J .
LIPIDS, 1987, 22 (11) :967-969
[9]   THE EQUAL EFFECTIVENESS RATIO - A QUANTITATIVE APPROACH TO THE EVALUATION OF COMPOUNDS FOR BORON NEUTRON-CAPTURE THERAPY [J].
BOND, VP ;
LASTER, BH ;
WIELOPOLSKI, L .
RADIATION RESEARCH, 1995, 141 (03) :287-293
[10]   BSH DISTRIBUTIONS IN THE CANINE HEAD AND A HUMAN PATIENT USING B-11 MRI [J].
BRADSHAW, KM ;
SCHWEIZER, MP ;
GLOVER, GH ;
HADLEY, JR ;
TIPPETS, R ;
TANG, PP ;
DAVIS, WL ;
HEILBRUN, MP ;
JOHNSON, S ;
GHANEM, T .
MAGNETIC RESONANCE IN MEDICINE, 1995, 34 (01) :48-56